Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples